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Purpose. To evaluate the results of patient symptoms and radiologic outcomes of cystoretroperitoneal shunt (CRS) technique in
the treatment of symptomatic simple renal cysts. Patients and Methods. In a prospective study, 37 patients with a simple renal cyst
were treated with ultrasound-guided percutaneous CRS-catheter. Radiological success was indicated as no recurrence of the cyst
or a reduction in cyst volume by at least half. Results. CRS technique was performed successfully in 36 patients with a simple renal
cyst. The mean size of all cysts decreased from 8.8cm (range 7 to 14) to 1.7cm (range 0 to 9; P<. 001). Symptomatic success
(pain relief) was achieved in 29/36 (80.5%) of patients, and radiographic success was achieved in 23/36 (63.8%) of patients, with
a median follow-up of 16 months (range 6 to 24). Conclusion. Ultrasound-guided percutaneous CRS technique for simple renal
c y s t si sf a s t ,s a f e ,e ﬀective, and inexpensive.
Copyright © 2009 Onder Canguven et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Simple renal cysts are common, with incidence increasing
with age from 0.22–0.55% in children to >5% in the fourth
decade, and up to 36% in the eighth decade of life [1]. The
Bosniak renal cyst classiﬁcation was ﬁrst introduced in 1986
and has been accepted by urologists and radiologists as a way
of diagnosing, discussing, and determining the management
approach to cystic renal masses [2]. The vast majority of
renal cysts are simple; they are thin and smooth-walled, with
no calciﬁcation, septation or enhancement after contrast
studies, corresponding to Bosniak category I [2].
Although simple renal cysts are usually asymptomatic,
ﬂank pain is the most common symptom. A palpable ﬂank
mass, hematuria, hypertension, and compression of the
pelvicaliceal system also can occur [3]. Pain, infection, and
obstructive uropathy are the major indicators for surgical
intervention [3]. Operations can be performed by open
surgery, percutaneous aspiration, with or without sclerosis,
and, most recently, laparoscopic surgery [1, 3].
Open surgical cyst decortication for pain relief through
an abdominal incision is associated with considerable
morbidity and protracted convalescence [3]. Percutaneous
aspiration presents minimally invasive management but,
because of frequent relapses, sclerotherapy is advised after
cyst aspiration [1]. Treatment with the sclerosing agents
varies signiﬁcantly among studies with respect to the time
of exposure to agents, concentration and volume, and
number of sclerotherapy sessions [1, 4, 5]. Laparoscopic
decortication of cysts is less invasive than open surgery;
however, the procedure is expensive and both procedures
must be performed under general anesthesia [1].
Open surgical or laparoscopic decortication of cysts
creates a window between the renal cyst and retroperitoneal
area. We designed a new technique in order to achieve
the same goal and eliminate the risks associated with
both surgeries. In this study, we describe and analyze the
feasibility,safety,andeﬃcancyof“cystoretroperitonealshunt
(CRS) technique” in simple renal cysts.
2. Patients andMethods
From April 2004 through February 2008, 37 patients under-
went the CRS technique for symptomatic simple renal cysts.2 Advances in Urology
The study was approved by the local ethics committee.
All patients signed a detailed consent form that listed
details about the procedure and possible complications. All
cysts were unilateral, single and in Bosniak category I [2].
Complex cysts, pregnant patients, and patients with solitary
kidney were not included in this study.
2.1. Measurements and Follow-Up. All patients were evalu-
ated in the urology clinic, where the cysts were localized and
characterized by ultrasonography. Additionally, computed
tomography was performed for Bosniak classiﬁcation. The
volume of the cysts was calculated with an ellipsoid formula,
whereby the product of the three orthogonal diameters was
multiplied by 0.52 (volume = height × width × length
× 0.52). The volume of the cyst was compared to that
estimated before treatment and represented as a percentage
of the initial value. Radiological success was designated as
no recurrence of the cyst or a reduction in pretreatment
cyst volume by at least half. The following studies were also
p e r f o r m e da te n r o l l m e n t :a f t e r7d a y s ,a n da f t e r1 ,3 ,6 ,9 ,
12, 18, and 24 months, clinical examination and laboratory
tests that included urinalysis, serum creatinine level, and
coagulation proﬁle.
Flank pain and mass, hypertension, and hematuria were
documented before treatment. The subjects were considered
to have hypertension based on data obtained from their
histories and if the values of their systolic/diastolic blood
pressure were 140/90mm Hg or greater. The blood pressure
measurementwasconductedonthedaybeforetheprocedure
and at each examination during the follow-up period. The
patients were also asked if they did or did not have pain. The
severity of pain was not evaluated.
2.2. Technique. The CRS technique was performed with
a single step 7 French ×50cm drainage ring catheter
(Angiotech, PBN Medicals, Denmark) (Figure 1). The
catheter had 32 side holes and hydrophilic coating for
minimalfrictionduringinsertion. Withthepatientinaﬂank
position for a retroperitoneal approach and after determi-
nation of the puncture site, antiseptic preparation and local
anesthesia with 2% lidocaine hydrochloride (1mg/kg) was
given before a small puncture wound was made on the skin.
The CRS-catheter was inserted until it reached the opposite
wall of the cyst cavity under ultrasound guidance (Figure 2).
As much cystic ﬂuid as possible was aspirated through the
catheter, and the volume of aspirated ﬂuid was recorded.
A ﬂuid sample was sent for bacteriologic and cytologic
examinations. In order to secure it, the catheter was sutured
withanonabsorbablematerial(4–0NylonorProlenesuture)
at two diﬀerent sites subcutaneously (approximately 0.5cm
below the skin surface, as shown in Figure 3). After suturing
subcutaneously, the CRS-catheter was cut above the sutures
and just below the skin. The skin, which was about 1cm,
was closed with the same nonabsorbable suture material,
which was removed after 7 days. After the procedure, the
patient rested in bed for 2 hours and was discharged from
the hospital on the same day. We removed the CRS-catheter
Figure1:SevenFrench ×50cmpolyethylenedrainageringcatheter.
Figure 2: CRS-catheter is introduced until reached the opposite
wall of the cyst cavity under ultrasound guidance.
after 3 months with a small incision made on the introduced
area, the sutures cut, and the catheter easily removed.
2.3. Statistical Analysis. Statistical analyses were performed
with GraphPad Prism 4 software for Windows. Student’s t,
Mann Whitney and Fisher’s exact tests were done. A value of
P<. 05 was considered signiﬁcant.
3. Results
T h es u b j e c t sw e r e1 5m e na n d2 2w o m e nw i t ham e d i a n
age of 48.5 years (36–65 years) (Table 1). The median
operative time (from skin incision to placement of ﬁnal
dressing) was 29 minutes (range 22 to 46). The mean
size of all cysts decreased from 8.8cm (range 7 to 14)
to 1.7cm (range 0 to 9; P<. 001). The mean volume
of the cysts was 354.8 ± 38.3mL (range, 170–924mL).
The cysts volume dropped less than 50mL in volume in
all patients (100%) in 24 hours after the CRS-catheter
insertion. During follow-up period, one (2.7%) of the cysts
recurred shortly after disappearance. We excluded that case
from our study group when the catheter was found out
of the cyst. The disappearance of the cyst was sustained
in other patients 36/37 (97.3%) until the CRS-catheters
were removed (Figures 4 and 5). Flank pain was present to
variable degrees in all patients before treatment. The ﬂank
pain later subsided in all patients whether resolution of the
cyst was complete or partial. Symptomatic success (pain
relief) after removing of the CRS-catheter was accomplishedAdvances in Urology 3
10 cm
Figure 3:SchematizationofCRStechnique.Blackarrows:suturesat
two diﬀerent sites. White arrow: CRS-catheter after the introducer
needle taken out.
Table 1: Patient characteristics and preoperative parameter.
Patients (n) 37
Male/female (n) 15/22
Age (yr)
Mean 48.5
Range 36–65
Side (n)
Right 12
Left 25
Cyst size (cm)
Mean 8.8
Range 6–14
Previous cyst aspirations (%) 5 (13.8%)
in 29/36 (80.5%) of patients, and radiological success was
gained in 23/36 (63.8%) of patients, with a median follow-
up of 16 months (range 3 to 24). The radiological success
probability of giant cysts (>350mL) diﬀered signiﬁcantly
from smaller cysts (<350mL; P<. 05). The mean volume of
therecurrentcystswas180.5±73.5mL(range,107–264mL).
Only patients with giant cysts underwent further treatment
with percutaneous aspiration with ethanol injection. Only
seven patients (19.5%) with a giant cyst and persistent pain
underwent further treatment with percutaneous aspiration
with ethanol injection. Aspiration with ethanol injection
alleviated pain in all the patients. Four patients had no pain
and three reported decrease in its severity.
For the 13 patients with associated hypertension, six
(46.1%) had well-controlled blood pressure with no medica-
tion after the decrease in cyst size. One patient had a wound
site infection three days after insertion of the catheter, which
was resolved by oral antibiotherapy (ciproﬂoxacin 500mg
oral tablet, two times a day). Microbiologic and cytologic
investigations revealed normal ﬁndings.
4. Discussion
This study reports on a new CRS-technique used with 37
patients and a median follow-up of 16 months. Radiological
success was achieved after catheter removal in 63.8% of
patients. Flank pain was present to variable degrees in all
patients before treatment. Ultrasonography and computed
tomography were used both for diagnosis of renal cyst and
to rule out nonrenal etiology for pain. Following treatment,
the ﬂank pain subsided in all patients whether resolution
of the cyst was complete or partial. Symptomatic success
(pain relief) was accomplished in 80.5% of patients after
removing the CRS-catheter. Laparoscopic decortication is
eﬀective and some authors recommended it as the next
step for a recurrence after simple aspiration that initially
relieved the pain [1]. We did not consider laparoscopic
decortication after failure of CRS-catheter treatment due
to possible ﬁbrotic changes in the retroperitoneal area and
decided to perform aspiration with ethanol injection.
Hypertension associated with simple renal cysts is likely
to disappear after treatment. In our study, six hypertensive
patients (46.1%) beneﬁted from treatment with normaliza-
tion of blood pressure. Similarly, Touloupidis et al. found
that, of 61 patients with hypertension, 29 had improved
blood pressures after sclerotherapy of simple renal cysts [6].
Renal cysts are common in the adult population [1].
With a mean follow-up 9.9 years, Terada et al. demonstrated
that the average rate of cyst enlargement was 3.9% per
year [7]. Treatment is indicated in patients with ﬂank or
abdominal pain or complications, such as collecting-system
obstruction or hypertension. Symptomatic renal cysts have
conventionally been treated by percutaneous aspiration with
or without injection of sclerosing agents; however, this has a
high rate of recurrence [4, 5] .T h er e c u r r e n c er a t eo fs i m p l e
aspiration with or without sclerosing agent varies between
41%–78% [8, 9] and 32%–100% [10, 11], respectively.
Among these various sclerosing agents, ethanol has been
widely used since the initial report by Bean [8]. However,
the leakage of alcohol from the cyst results in necrosis of
the surrounding tissue. Moreover, the systemic diﬀusion
of alcohol may induce central nervous system depression
[5]. Several sclerosing agents (e.g., sodium tetradecyl sulfate
and povidone-iodine) have been used to diminish side
eﬀects and increase success rates [5, 12–14]. Demir et al.
demonstrated that ethanol and sodium tetradecyl sulfate are
well-tolerated sclerosants for the treatment of simple renal
cysts [5]. However, they preferred the latter agent as a ﬁrst
choice because it causes less pain. Madeb et al. showed that
povidone-iodine sclerotherapy was followed by a high rate of
recurrence and, therefore, not indicated for the treatment of
symptomatic simple renal cysts [12].
Laparoscopic decortication of symptomatic renal cysts
has been used since the early 1990s [15, 16]. Although
the laparoscopic approach to simple renal cysts is eﬀective,
technical demands and costs currently limit widespread
application. Various investigators have reported high success
rates for laparoscopic interventions [3, 17]. However, Shi-
raishi et al. showed that radiological failure could be seen in
up to 19% of patients in the long-term (mean follow-up of4 Advances in Urology
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Figure 4: Left simple renal cyst before treatment.
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Figure 5: Six weeks after treated with CRS-technique. Black arrow: renal cyst component of CRS-catheter. White arrow: retroperitoneal
component of CRS-catheter.
67.2 months), which was rather disappointing compared to
the short-term results [15].
Previous studies suggested that cyst recurrence after
sclerotherapy was a result of inadequate sclerosis of the cyst
wall epithelial cells, which continued to produce ﬂuid into
the cyst [1]. The secretory activity of the residual cyst wall
after decortication is also contributory in cystic recurrence.
The needle puncture site for sclerotherapy appears to close
soon afterward and does not provide drainage of the cyst.
In our technique, we wanted to leave the puncture site
open longer. Therefore, the shunt would continue to carry
cystic ﬂuid into the retroperitoneal area. We achieved success
to some degree with symptomatic relief for the patients.
Another explanation might be the ﬁbrotic action inside
the cyst wall. Fibrosis might have decreased the cyst to a
smaller size, especially in giant cysts. Since the cyst shapes
of the treated patients were spherical and smaller rather than
aspheric, we believe that a permanent window was created
after removal of the CRS-catheter.
As in other studies, there was an obvious diﬀerence
between radiologic and symptomatic success in our study [3,
15]. All studies revealed that the remaining cyst, irrespective
of its size, was not always associated with symptoms.
Although the success rate after removal of the catheter was
similar to other reported success rates, CRS could be an
innovative technique with lifelong biocompatible material.
Moreover, the CRS technique can easily be done under local
anesthesia in an outpatient clinic.
The major limitation of our study was the lack of a
control group for comparison of our results. We might have
randomly assigned patients into two groups [4, 5]i na
prospective controlled design. However, we could compare
ourresultstothose ofpreviousstudies. Inthe future,weplan
to carry out this technique with biocompatible catheters. By
that time, we will also have obtained the long-term results of
the patient group.
In conclusion, the CRS-technique is minimally invasive,
well-tolerated, and easily administered under ultrasoundAdvances in Urology 5
guidance and does not require hospital admission. It can be
oﬀered to patients who may prefer to avoid risks associated
with sclerosing agents and general anesthesia. As for every
novel technique, further larger and controlled studies are
needed to evaluate the value of the CRS-technique in the
treatment of symptomatic simple renal cysts.
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